SCHEMBL4824564

SCHEMBL4824564

CCOc1cc(C(O)c2ccc(OC)c(O[Si](C)(C)C(C)(C)C)c2)ccc1OC

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
DRD2 P14416 1/20 0.42
ACHE P22303 1/20 0.41
HPGD P15428 1/20 0.41
PDE4A P27815 8/20 0.40
PDE4B Q07343 8/20 0.40
PDE4C Q08493 8/20 0.40
PDE4D Q08499 8/20 0.40
PPARG P37231 1/20 0.40
PPARD Q03181 1/20 0.40
PPARA Q07869 1/20 0.40
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39
HIF1A Q16665 1/20 0.39
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4818551 0.85 PPARG (0.51) ALDH1A1SMN1; SMN2L3MBTL1ACHEPDE4A
SCHEMBL30504079 0.84 TUBB4A (0.46) ALDH1A1SMN1; SMN2DRD2ACHEHPGD
SCHEMBL30504081 0.84 TUBB4A (0.46) ALDH1A1SMN1; SMN2DRD2ACHEHPGD
SCHEMBL4821120 0.83 ACHE (0.40) SMN1; SMN2L3MBTL1DRD2ACHEPDE4A
SCHEMBL5635730 0.81 PPARG (0.42) L3MBTL1DRD2ACHEHPGDPPARG
SCHEMBL4824733 0.80 MAPK1 (0.53) ALDH1A1SMN1; SMN2DRD2ACHEHPGD
SCHEMBL15004196 0.79 DRD2 (0.47) SMN1; SMN2L3MBTL1DRD2ACHEPDE4A
SCHEMBL10702236 0.78 PDE4A (0.53) ALDH1A1SMN1; SMN2L3MBTL1PDE4APDE4B
SCHEMBL4827029 0.78 PDE4A (0.50) ALDH1A1SMN1; SMN2L3MBTL1ACHEPDE4A
SCHEMBL4823200 0.78 DRD2 (0.40) SMN1; SMN2L3MBTL1DRD2ACHEPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7470723-B2 Diphenylethylene compounds and uses thereof CELGENE CORPORATION (US) 2008-12-30 US disclosed
EP-1799634-A2 DIPHENYLETHYLENE COMPOUNDS AND USES THEREOF CELGENE CORPORATION (US) 2007-06-27 EP disclosed
WO-2006026747-A2 DIPHENYLETHYLENE COMPOUNDS AND USES THEREOF CELGENE CORPORATION (US) 2006-03-09 WO disclosed
US-20050107339-A1 Diphenylethylene compounds and uses thereof CELGENE CORPORATION 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107339-A1 Diphenylethylene compounds and uses thereof VHL, TNF, PTGES ALDH1A1 124/4885SMN1; SMN2 2969/4885L3MBTL1 2413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.